Submitted by: Submitted by sankp
Views: 10
Words: 479
Pages: 2
Category: Business and Industry
Date Submitted: 05/23/2016 12:13 AM
Pulmonary Fibrosis Market Size, Share, Analysis and Causes, Symptoms, Treatment, Pipeline Review, H1 2016
Global Markets Direct's, ‘Pulmonary Fibrosis - Pipeline Review, H1 2016', provides an overview of the Pulmonary Fibrosis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Pulmonary Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Fibrosis and features dormant and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/pulmonary-fibrosis-pipeline-review-h1-2016
Reasons to Buy
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Table of Content
Table of Contents 2
List of Tables 7
Browse Upcoming Reports @ http://www.radiantinsights.com/upcoming-reports
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Pulmonary Fibrosis Overview 11
Therapeutics Development 12
Pipeline Products for Pulmonary...